110 related articles for article (PubMed ID: 7690311)
21. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings.
Insler V; Shoham Z; Barash A; Koistinen R; Seppälä M; Hen M; Lunenfeld B; Zadik Z
Hum Reprod; 1993 Mar; 8(3):379-84. PubMed ID: 7682564
[TBL] [Abstract][Full Text] [Related]
22. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
25. Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease.
Aakvaag A; Gjønnaess H
Br J Obstet Gynaecol; 1985 Dec; 92(12):1258-64. PubMed ID: 3936533
[TBL] [Abstract][Full Text] [Related]
26. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
27. Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome.
Morris RS; Carmina E; Vijod MA; Stanczyk FZ; Lobo RA
Fertil Steril; 1995 Apr; 63(4):742-6. PubMed ID: 7534239
[TBL] [Abstract][Full Text] [Related]
28. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity.
Weaver JU; Holly JM; Kopelman PG; Noonan K; Giadom CG; White N; Virdee S; Wass JA
Clin Endocrinol (Oxf); 1990 Sep; 33(3):415-22. PubMed ID: 1701370
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
30. Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome.
Bützow TL; Kettel LM; Yen SS
Fertil Steril; 1995 Jun; 63(6):1200-3. PubMed ID: 7750589
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
Anttila L; Ding YQ; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
[TBL] [Abstract][Full Text] [Related]
32. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
[TBL] [Abstract][Full Text] [Related]
33. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
34. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist.
Gadir AA; Alnaser HM; Mowafi RS; Shaw RW
Fertil Steril; 1992 Feb; 57(2):309-13. PubMed ID: 1735480
[TBL] [Abstract][Full Text] [Related]
35. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
Burger CW; Hompes PG; Korsen TJ; Schoemaker J
Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
[TBL] [Abstract][Full Text] [Related]
36. The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial.
Mehrabian F; Eessaei F
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S42-4. PubMed ID: 22768457
[TBL] [Abstract][Full Text] [Related]
37. Changes of bioactive luteinizing hormone after laparoscopic ovarian cautery in patients with polycystic ovarian syndrome.
Sakata M; Tasaka K; Kurachi H; Terakawa N; Miyake A; Tanizawa O
Fertil Steril; 1990 Apr; 53(4):610-3. PubMed ID: 2138570
[TBL] [Abstract][Full Text] [Related]
38. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.
Anttila L; Koskinen P; Jaatinen TA; Erkkola R; Irjala K; Ruutiainen K
Hum Reprod; 1993 Aug; 8(8):1179-83. PubMed ID: 8408513
[TBL] [Abstract][Full Text] [Related]
39. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
[TBL] [Abstract][Full Text] [Related]
40. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease.
Suikkari AM; Ruutiainen K; Erkkola R; Seppälä M
Hum Reprod; 1989 Feb; 4(2):136-9. PubMed ID: 2465307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
